Your browser doesn't support javascript.
Longstanding Phenytoin Use as a Cause of Progressive Dyspnea.
Walker, Alexander; Rupal, Arashdeep; Jani, Chinmay; Al Omari, Omar; Singh, Harpreet; Patel, Dipesh; Perrino, Carmen; McCannon, Jessica.
  • Walker A; Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA. Electronic address: alexander.walker@mah.harvard.edu.
  • Rupal A; Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA.
  • Jani C; Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA.
  • Al Omari O; Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA.
  • Singh H; Department of Pulmonary and Critical Care, Medicine College of Wisconsin, Milwaukee, WI.
  • Patel D; Harvard Medical School, Boston, MA; Department of Radiology, Mount Auburn Hospital, Cambridge, MA.
  • Perrino C; Department of Pathology, Mount Auburn Hospital, Cambridge, MA.
  • McCannon J; Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA; Division of Pulmonary and Critical Care Medicine, Mount Auburn Hospital, Cambridge, MA.
Chest ; 161(2): e91-e96, 2022 02.
Article in English | MEDLINE | ID: covidwho-1664780
ABSTRACT
CASE PRESENTATION A 54-year-old South African man with a medical history of type 2 diabetes mellitus, seizure disorder, OSA, and latent TB presented to the ER with gradually progressive dyspnea over months. He also reported occasional dry cough and fatigue at presentation but denied fever, chills, chest pain, leg swelling, palpitations, or lightheadedness. He was treated with a course of levofloxacin for presumed community-acquired pneumonia as an outpatient without improvement and had tested negative for COVID-19. He denied occupational or environmental exposures or sick contacts, though he had traveled back to South Africa 1 year before presentation. He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily). His other home medications included dulaglutide, sertraline, and atorvastatin and had no recent changes. He quit smoking 30 years ago after smoking one pack per day for 10 years.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Phenytoin / Seizures / Lung Diseases, Interstitial / Drug Substitution / Lacosamide / COVID-19 / Lung Type of study: Case report / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Chest Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Phenytoin / Seizures / Lung Diseases, Interstitial / Drug Substitution / Lacosamide / COVID-19 / Lung Type of study: Case report / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Chest Year: 2022 Document Type: Article